Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zealand Pharma A/S
DescriptionDual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Molecular Target Glucagon-like peptide-1 (GLP-1) ; Glucose-dependent insulinotropic polypeptide (GIP) receptor
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today